Insider · CIK 0000935679
Garo H Armen
Files at PTIX (Protagenic Therapeutics, Inc.\new), AGEN (AGENUS INC). First filing Feb 15, 2024, latest Aug 24, 2026.
In brief
Garo H Armen files SEC Form 4 as director, chair and 10% owner at PTIX (Protagenic Therapeutics, Inc.\new), and also at AGEN (AGENUS INC). Since Feb 15, 2024, Garo H Armen has reported 8 open-market buys worth $355k and 0 open-market sells worth $0, the latest filed on Aug 24, 2026.
A track record needs three past buys with six months of prices behind them; Garo H Armen has 0, so none is measured yet.
The newest scored trade: bought $13k of PTIX on Aug 21, 2026, filed Aug 24, 2026, scored 31 (weak). In the last 12 months: 7 buys worth $31k and 0 sells worth $0.
Where the trades landed
Last year at the 2 companies this insider has traded most, with each buy and sell on the bar it happened.
PTIX: Protagenic Therapeutics, Inc.\new
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
AGEN: AGENUS INC
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 31Weak | PTIXbuy Protagenic Therapeutics, Inc.\new | $13k 20,000 shares | +37% | - | |
| 28Weak | PTIXbuy Protagenic Therapeutics, Inc.\new | $945 2,700 shares | +8% | - | |
| 31Weak | PTIXbuy Protagenic Therapeutics, Inc.\new | $9,811 16,634 shares | +45% | - | |
| 28Weak | PTIXbuy Protagenic Therapeutics, Inc.\new | $710 2,220 shares | +7% | - | |
| 25Weak | PTIXbuy Protagenic Therapeutics, Inc.\new | $151 685 shares | +2% | - | |
| 28Weak | PTIXbuy Protagenic Therapeutics, Inc.\new | $1,294 5,000 shares | +19% | - | |
| 28Weak | PTIXbuy Protagenic Therapeutics, Inc.\new | $4,806 26,291 shares | - | - | |
| 47Moderate | AGENbuy AGENUS INC | $324k 500,000 shares | +397% | +16% from low-70% from high |
Transactions
The newest 50 of 90 rows this insider has filed.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Aug 21, 2026 | PTIX Protagenic Therapeutics, Inc.\new | POpen-market purchase COMMON STOCK | +20,000 | $0.65 | $13k | 73,533 | Aug 24, 2026 |
| Aug 19, 2026 | PTIX Protagenic Therapeutics, Inc.\new | POpen-market purchase COMMON STOCK | +2,700 | $0.35 | $945 | 36,899 | Aug 20, 2026 |
| Aug 20, 2026 | PTIX Protagenic Therapeutics, Inc.\new | POpen-market purchase COMMON STOCK | +16,634 | $0.59 | $9,811 | 53,533 | Aug 20, 2026 |
| Aug 11, 2026 | PTIX Protagenic Therapeutics, Inc.\new | POpen-market purchase COMMON STOCK | +2,220 | $0.32 | $710 | 34,199 | Aug 12, 2026 |
| Aug 10, 2026 | AGEN AGENUS INC | AGrant or award Stock Optionderivative | +1,971,500 | $0.00 | $0 | 1,971,500 | Aug 12, 2026 |
| Aug 6, 2026 | PTIX Protagenic Therapeutics, Inc.\new | POpen-market purchase COMMON STOCK | +685 | $0.22 | $151 | 31,979 | Aug 10, 2026 |
| Aug 5, 2026 | PTIX Protagenic Therapeutics, Inc.\new | POpen-market purchase COMMON STOCK | +5,000 | $0.26 | $1,294 | 31,294 | Aug 6, 2026 |
| Jul 30, 2026 | PTIX Protagenic Therapeutics, Inc.\new | POpen-market purchase COMMON STOCK | +26,291 | $0.18 | $4,806 | 26,291 | Aug 3, 2026 |
| Jul 10, 2026 | AGEN AGENUS INC | AGrant or award Common Stock | +4,852 | $3.35 | $16k | 371,108 | Jul 14, 2026 |
| Jun 26, 2026 | AGEN AGENUS INC | AGrant or award Common Stock | +5,364 | $3.03 | $16k | 366,256 | Jun 30, 2026 |
| Jun 12, 2026 | AGEN AGENUS INC | AGrant or award Common Stock | +4,925 | $3.30 | $16k | 360,892 | Jun 16, 2026 |
| May 29, 2026 | AGEN AGENUS INC | AGrant or award Common Stock | +4,644 | $3.50 | $16k | 355,967 | Jun 2, 2026 |
| May 15, 2026 | AGEN AGENUS INC | AGrant or award Common Stock | +4,540 | $3.58 | $16k | 351,323 | May 19, 2026 |
| May 1, 2026 | AGEN AGENUS INC | AGrant or award Common Stock | +4,233 | $3.84 | $16k | 346,783 | May 5, 2026 |
| Apr 24, 2026 | AGEN AGENUS INC | AGrant or award Stock Optionderivative | +1,000,000 | $0.00 | $0 | 1,000,000 | Apr 28, 2026 |
| Apr 24, 2026 | AGEN AGENUS INC | AGrant or award Stock Optionderivative | +27,750 | $0.00 | $0 | 27,750 | Apr 28, 2026 |
| Apr 24, 2026 | AGEN AGENUS INC | AGrant or award Stock Optionderivative | +137,550 | $0.00 | $0 | 137,550 | Apr 28, 2026 |
| Apr 17, 2026 | AGEN AGENUS INC | AGrant or award Common Stock | +3,403 | $4.79 | $16k | 342,550 | Apr 21, 2026 |
| Apr 3, 2026 | AGEN AGENUS INC | AGrant or award Common Stock | +4,629 | $3.33 | $15k | 339,147 | Apr 6, 2026 |
| Mar 20, 2026 | AGEN AGENUS INC | AGrant or award Common Stock | +3,983 | $3.71 | $15k | 334,518 | Mar 24, 2026 |
| Mar 6, 2026 | AGEN AGENUS INC | AGrant or award Common Stock | +4,994 | $2.96 | $15k | 330,535 | Mar 9, 2026 |
| Feb 20, 2026 | AGEN AGENUS INC | AGrant or award Common Stock | +4,829 | $3.06 | $15k | 325,541 | Feb 24, 2026 |
| Feb 6, 2026 | AGEN AGENUS INC | AGrant or award Common Stock | +5,027 | $2.94 | $15k | 320,712 | Feb 9, 2026 |
| Jan 23, 2026 | AGEN AGENUS INC | AGrant or award Common Stock | +4,562 | $3.24 | $15k | 315,685 | Jan 26, 2026 |
| Jan 9, 2026 | AGEN AGENUS INC | AGrant or award Common Stock | +3,780 | $3.91 | $15k | 311,123 | Jan 12, 2026 |
| Dec 26, 2025 | AGEN AGENUS INC | AGrant or award Common Stock | +4,942 | $3.31 | $16k | 307,343 | Dec 29, 2025 |
| Dec 12, 2025 | AGEN AGENUS INC | AGrant or award Common Stock | +4,316 | $3.79 | $16k | 302,401 | Dec 15, 2025 |
| Nov 28, 2025 | AGEN AGENUS INC | AGrant or award Common Stock | +3,587 | $4.56 | $16k | 298,085 | Dec 1, 2025 |
| Nov 14, 2025 | AGEN AGENUS INC | AGrant or award Common Stock | +3,769 | $4.34 | $16k | 294,498 | Nov 17, 2025 |
| Oct 31, 2025 | AGEN AGENUS INC | AGrant or award Common Stock | +4,120 | $3.97 | $16k | 290,729 | Nov 5, 2025 |
| Oct 17, 2025 | AGEN AGENUS INC | AGrant or award Common Stock | +4,216 | $3.88 | $16k | 286,609 | Oct 21, 2025 |
| Oct 3, 2025 | AGEN AGENUS INC | AGrant or award Common Stock | +3,951 | $4.14 | $16k | 282,393 | Oct 6, 2025 |
| Sep 19, 2025 | AGEN AGENUS INC | AGrant or award Common Stock | +3,734 | $4.38 | $16k | 278,442 | Sep 23, 2025 |
| Sep 5, 2025 | AGEN AGENUS INC | AGrant or award Common Stock | +3,778 | $4.33 | $16k | 274,708 | Sep 9, 2025 |
| Aug 22, 2025 | AGEN AGENUS INC | AGrant or award Common Stock | +3,619 | $4.52 | $16k | 270,930 | Aug 26, 2025 |
| Aug 8, 2025 | AGEN AGENUS INC | AGrant or award Common Stock | +3,407 | $4.80 | $16k | 267,311 | Aug 11, 2025 |
| Jul 25, 2025 | AGEN AGENUS INC | AGrant or award Common Stock | +2,745 | $5.96 | $16k | 263,904 | Jul 28, 2025 |
| Jul 11, 2025 | AGEN AGENUS INC | AGrant or award Common Stock | +2,317 | $7.06 | $16k | 261,159 | Jul 15, 2025 |
| Jun 18, 2025 | AGEN AGENUS INC | AGrant or award Common Stock | +61,397 | $4.47 | $274k | 255,406 | Jun 30, 2025 |
| Jun 27, 2025 | AGEN AGENUS INC | AGrant or award Common Stock | +3,436 | $4.76 | $16k | 258,842 | Jun 30, 2025 |
| Jun 17, 2025 | AGEN AGENUS INC | AGrant or award Stock Optionderivative | +37,500 | $0.00 | $0 | 37,500 | Jun 20, 2025 |
| Jun 13, 2025 | AGEN AGENUS INC | AGrant or award Common Stock | +3,480 | $4.70 | $16k | 194,009 | Jun 17, 2025 |
| May 30, 2025 | AGEN AGENUS INC | AGrant or award Common Stock | +4,769 | $3.43 | $16k | 190,529 | Jun 3, 2025 |
| May 16, 2025 | AGEN AGENUS INC | AGrant or award Common Stock | +4,700 | $3.48 | $16k | 185,750 | May 20, 2025 |
| May 2, 2025 | AGEN AGENUS INC | AGrant or award Common Stock | +5,260 | $3.11 | $16k | 181,060 | May 5, 2025 |
| Apr 18, 2025 | AGEN AGENUS INC | AGrant or award Common Stock | +7,886 | $2.08 | $16k | 175,800 | Apr 22, 2025 |
| Apr 4, 2025 | AGEN AGENUS INC | AGrant or award Common Stock | +10,288 | $1.56 | $16k | 167,914 | Apr 8, 2025 |
| Mar 21, 2025 | AGEN AGENUS INC | AGrant or award Common Stock | +9,243 | $1.61 | $15k | 157,626 | Mar 24, 2025 |
| Mar 7, 2025 | AGEN AGENUS INC | AGrant or award Common Stock | +6,332 | $2.35 | $15k | 148,383 | Mar 11, 2025 |
| Feb 21, 2025 | AGEN AGENUS INC | AGrant or award Common Stock | +4,483 | $3.32 | $15k | 142,051 | Feb 25, 2025 |
Questions about Garo H Armen
Answered from the filings on this page, as of the latest one.
Is Garo H Armen buying or selling?
In the last 12 months Garo H Armen reported 7 open-market buys worth $31k and 0 open-market sells worth $0 on SEC Form 4; the latest was bought $13k of PTIX on Aug 21, 2026. Grants, option exercises and tax withholding are not counted.
How did Garo H Armen's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Garo H Armen has 0.
Where does Garo H Armen file Form 4?
Garo H Armen has filed Form 4 at PTIX (Protagenic Therapeutics, Inc.\new) as Executive Chairman; AGEN (AGENUS INC) as See Remarks. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.